EC ever use among women of reproductive age: 0.5% (DHS 2007)
EC knowledge among women of reproductive age: 9.3% (DHS 2007)
Contraceptive Use: 56.3% (DHS 2007, ever use of a modern method among women of reproductive age)
Registered LNG-EC products:
- Lenor 72 - Available only with prescription
- Pregnon - Available only with prescription
- Revoke 72* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: Essential Medicines List, Post-rape care guidelines
Other relevant information: EC distributed via IPPF outlets (500 - 1,000 in 2012).
In Zambia, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is nurses, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).
For more information, see below: